Get started
Author

Tim H. Ward

Observed names: T H Ward, T Ward, T. H. Ward, T. Ward, T.H Ward, T.H. Ward, TH Ward, Tim H Ward, Tim Ward, Ward Th, Ward, T, Ward, Tim
Observed institutions: National Health Service, University of Leeds, University of Cambridge, Manchester Academic Health Science Centre, Western General Hospital, Cancer Research UK, Southampton General Hospital, Manchester Royal Infirmary, Edinburgh Cancer Research, University of Manchester, University of Rochester Medicine, Cancer Research UK Manchester Institute, The Christie Hospital, The Christie NHS Foundation Trust, Aegera Therapeutics (Canada), Addenbrooke's Hospital, Cancer Research UK Manchester Centre, National Cancer Research Institute
ORCID: 0009-0005-5633-9972
Observed ORCID: 0009-0005-5633-9972
OpenAlex ID: A5013301618
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
2011 · Matthew G. Krebs, Robert Sloane, et al. · Journal of Clinical Oncology · 885
PDF
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
2012 · Jian-Mei Hou, Matthew G. Krebs, et al. · Journal of Clinical Oncology · 858
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
2011 · Matthew G. Krebs, Jian-Mei Hou, et al. · Journal of Thoracic Oncology · 478
PDF
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
2011 · Jian-Mei Hou, Matthew Krebs, et al. · American Journal Of Pathology · 441
PDF
Circulating tumour cells: their utility in cancer management and predicting outcomes
2010 · Matthew G. Krebs, Jian-Mei Hou, et al. · Therapeutic Advances in Medical Oncology · 269
PDF
Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies
2002 · G. C. Jayson, J. Zweit, et al. · JNCI Journal of the National Cancer Institute · 259
Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy
2009 · Jian-Mei Hou, Alastair Greystoke, et al. · American Journal Of Pathology · 246
PDF
DT-diaphorase: a target for new anticancer drugs
2004 · S Danson, T.H Ward, et al. · Cancer Treatment Reviews · 189
Biomarkers of apoptosis
2008 · T H Ward, J Cummings, et al. · British Journal of Cancer · 139
PDF
Biomarker method validation in anticancer drug development
2007 · J Cummings, T H Ward, et al. · British Journal of Pharmacology · 134
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
2019 · Petra Seibold, Adam Webb, et al. · Radiotherapy and Oncology · 112
PDF
ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer
2007 · Richard Booton, Tim Ward, et al. · Journal of Thoracic Oncology · 104
PDF
Phase I Trial of AEG35156 Administered as a 7-Day and 3-Day Continuous Intravenous Infusion in Patients With Advanced Refractory Cancer
2009 · Emma Dean, Duncan Jodrell, et al. · Journal of Clinical Oncology · 95
Hypoxia in head and neck cancer
2006 · A Y Isa, T H Ward, et al. · British Journal of Radiology · 86
Apoptosis pathway-targeted drugs—from the bench to the clinic
2004 · Jeff Cummings, Tim H. Ward, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 85
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma
2010 · Niladri Ghosal, Kathleen Mais, et al. · British Journal of Oral and Maxillofacial Surgery · 79
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP
2005 · J Cummings, T H Ward, et al. · British Journal of Cancer · 77
PDF
Optimisation of circulating biomarkers of cell death for routine clinical use
2008 · A. Greystoke, J. Cummings, et al. · Annals of Oncology · 76
Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma
2013 · Inna V. Linnik, Marietta L. J. Scott, et al. · Magnetic Resonance in Medicine · 71
Glutathione-S-Transferase P1 Isoenzyme Polymorphisms, Platinum-Based Chemotherapy, and Non-small Cell Lung Cancer
2006 · Richard Booten, Tim Ward, et al. · Journal of Thoracic Oncology · 68
PDF
Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity
2008 · Jeffrey Cummings, Cassandra Hodgkinson, et al. · Molecular Cancer Therapeutics · 65
PDF
Quantitative multiplexed quantum dot immunohistochemistry
2008 · E. Sweeney, T.H. Ward, et al. · Biochemical and Biophysical Research Communications · 63
Circulating Tumor Cells, Enumeration and Beyond
2010 · Jian-Mei Hou, Matthew Krebs, et al. · Cancers · 54
PDF
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma
2011 · A Greystoke, J P B O'Connor, et al. · British Journal of Cancer · 52
PDF
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
2010 · C Dive, R A Smith, et al. · British Journal of Cancer · 51
PDF
Works count: 124
Citation count: 6,136
H-index: 35
I10-index: 62
Year
Topic
Type